TotalMarketCap

Whitehawk Therapeutics

WHWKNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$173.877 M

$3.05 -3.79%

Close of 6 Nov 2026

As of 6 Nov 2026, Whitehawk Therapeutics (WHWK) has a market capitalization of $173.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.14M

#3198 by revenue

Earnings

-$20.6M

Loss-making

Shares outstanding

57,009,010

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #255Upstream BioUPB$175.8M
  2. #256BridgeBio Oncology TherapeuticsBBOT$175.2M
  3. #257Whitehawk TherapeuticsWHWK$173.9M
  4. #258Zentalis PharmaceuticalsZNTL$162.8M
  5. #259Oramed PharmaceuticalsORMP$162.6M

What if Whitehawk Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$495,305.46

Per share 162,395× higher

Bitcoin $1.53T

$26,800.12

Per share 8,787× higher

Apple $5.02T

$87,982.28

Per share 28,847× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Whitehawk Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.